Skip to content
DataLookout
Menu

NCT07883213

A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Prurigo Nodularis.

StatusNot Yet Recruiting
PhasePhase 2
SponsorAkeso
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Proportion of subjects with ≥4-point improvement from baseline in the Worst Itch Numerical Rating Scale (WI-NRS) at week 16
Timeframe: Up to week 16

Secondary (6)

Proportion of subjects with Investigator's Global Assessment score of 0 or 1 for PN stage (IGA PN-S) at efficacy Visit
Proportion of subjects with Investigator's Global Assessment score of 0 or 1 for PN Activity (IGA PN-A) at efficacy Visit
Change from the baseline in the WI-NRS at each other Visit
Change from baseline in Dermatology Life Quality Index (DLQI) score at efficacy Visit
Change from baseline in Hospital Anxiety and Depression Scale (HADS) at week 16
Show 1 moreShow less
Safety parameters

Arms and interventions

cohort 1:AK139 regiment 1Experimental
cohort 2:AK139 regiment 2Experimental
placeboPlacebo comparator

Biologicals: AK139

Other: Placebo